Literature DB >> 22678627

Directed glia-assisted angiogenesis in a mature neurosensory structure: pericytes mediate an adaptive response in human dental pulp that maintains blood-barrier function.

Ramin M Farahani1, Babak Sarrafpour, Mary Simonian, Qing Li, Neil Hunter.   

Abstract

The specialized tightly controlled microcirculation of craniofacial neurosensory organs is an essential evolutionary adaptation and yet a dilemma where angiogenic remodeling occurs. Despite extreme plasticity of neurosensory structures, the capacity to reconcile barrier phenotype of the microcirculation with an angiogenic cascade is not known. Here we provide primary evidence for such a response in an elemental neurosensory structure, human dental pulp, following chronic carious insult. In response to hypoxic challenge neurosensory odontoblasts express hypoxia-inducible factor-1α and notch-1. Associated radial rearrangement of astrocyte-like telacytes that communicate through a cell-poor zone with the microvasculature is observed. Activated pericytes characterized by expression of α-smooth muscle actin are located adjacent to the telacyte attachment to the vasculature. In this location, endothelial expression of sonic hedgehog parallels expression of notch-1 by pericytes. The angiogenic response is initiated by pericyte contraction and altered endothelial polarity and proliferation leading to intussusception of endothelial cells and extensive remodeling of basement membrane with upregulation of laminin-8 and laminin-5. These responses guide intravascular loop formation that maintains both intact basement membrane and tight junctions. This initial phase is followed by formation of anastomoses that enhance the hemodynamic capacity of the intravascular loops. The formation of anastomoses is mediated by extension of cytonemes from pericytes guided by MHC-II(+)/CD-163(+) microglia aligned with the telacytes. The cytonemes seek out pericytes on adjacent intravascular loops to initiate migration of endothelial cells. These findings support a new paradigm for understanding angiogenic capacity of neurosensory structures and aberrations of this response manifest as neurovasculopathies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22678627     DOI: 10.1002/cne.23162

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  HIF2α signaling inhibits adherens junctional disruption in acute lung injury.

Authors:  Haixia Gong; Jalees Rehman; Haiyang Tang; Kishore Wary; Manish Mittal; Pallavi Chaturvedi; You Yang Zhao; Pallavi Chatturvedi; Youyang Zhao; Yulia A Komarova; Yulia A Komorova; Stephen M Vogel; Asrar B Malik
Journal:  J Clin Invest       Date:  2015-01-09       Impact factor: 14.808

2.  Amelogenin as a regenerative endodontic molecule for immature teeth with apical periodontitis. An experimental study.

Authors:  Maha M F Mounir; Fatma M Rashed; Sahar M Bukhary
Journal:  J Oral Biol Craniofac Res       Date:  2022-08-28

3.  Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum.

Authors:  E C Azmitia; Z T Saccomano; M F Alzoobaee; M Boldrini; P M Whitaker-Azmitia
Journal:  J Autism Dev Disord       Date:  2016-04

Review 4.  Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis.

Authors:  Anji Xiong; Yi Liu
Journal:  Front Pharmacol       Date:  2017-05-30       Impact factor: 5.810

Review 5.  Neural crest cell-derived pericytes act as pro-angiogenic cells in human neocortex development and gliomas.

Authors:  Francesco Girolamo; Ignazio de Trizio; Mariella Errede; Giovanna Longo; Antonio d'Amati; Daniela Virgintino
Journal:  Fluids Barriers CNS       Date:  2021-03-20

6.  Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes.

Authors:  Saba Rezaei-Lotfi; Filip Vujovic; Mary Simonian; Neil Hunter; Ramin M Farahani
Journal:  Genome Biol       Date:  2021-12-09       Impact factor: 13.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.